Clinical Diagnostics and Research Tools

  1. 20 Apr 2023  |  Asia Pacific  |  Market Outlook

    Asia-Pacific Next-generation Diagnostics Outlook, 2023

    The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth

    The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...

    $4,950.00
  2. 03 Apr 2023  |  Global  |  Market Outlook

    Global Next generation Diagnostics, Outlook 2023

    Automation and Digitization Drive the Next Growth Phase Post-COVID-19

    As COVID-19 transitions to the endemic phase, automation solutions and smart, connected laboratories will catalyze recovery in the next-generation diagnostics industry. The COVID-19 pandemic left a lot of installed capacity in laboratories and healthcare centers. To take advantage of this situation, it is necessary for industry players to focus on ...

    $4,950.00
  3. 19 Dec 2022  |  North America  |  Market Outlook

    Top 10 for 2023: Growth Opportunities for the Life Sciences Industry

    An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...

    $2,450.00
  4. 14 Mar 2022  |  North America  |  Market Outlook

    Next-generation Diagnostics Outlook, 2022

    Recovery in Routine Testing and Focus on Personalized Diagnostics to Propel Growth

    In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

    $4,950.00
  5. 23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook

    Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020

    Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020

    In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

    $4,950.00
  6. 09 Apr 2018  |  North America  |  Market Outlook

    Global Life Sciences Industry Outlook, 2018

    Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments

    The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

    $4,950.00